Medicare price caps on the way, with official guidance on process

In the USA, the Department of Health and Human Services (HHS) has released its initial guidance for the implementation of a rebate program capping the price of certain medications provided under the Medicare insurance program.

The measures are being brought in under the  Inflation Reduction Act, which was signed into law last year after a long period of negotiation and congressional wrangling.

Under the scheme, drug companies will pay rebates to the US government for raising some prescription drug prices faster than the rate of inflation.